Sure, maybe it belongs in the public sector. But with current estimates of $1-5B R&D per successful new drug, it's not exactly chump change. The US gov't doesn'

Sure, maybe it belongs in the public sector. But with current estimates of $1-5B R&D per successful new drug, it's not exactly chump change. The US gov't doesn't have a couple spare hundred billion kicking around, ready to point at drug research. So that will be a long time coming...